SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-191140
Filing Date
2021-06-15
Accepted
2021-06-15 16:06:00
Documents
12
Period of Report
2021-06-11
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d169431d8k.htm   iXBRL 8-K 31460
  Complete submission text file 0001193125-21-191140.txt   158206

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA logc-20210611.xsd EX-101.SCH 3093
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE logc-20210611_lab.xml EX-101.LAB 18887
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE logc-20210611_pre.xml EX-101.PRE 11875
5 EXTRACTED XBRL INSTANCE DOCUMENT d169431d8k_htm.xml XML 3477
Mailing Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421
Business Address 65 HAYDEN AVE 2ND FLOOR LEXINGTON MA 02421 617-245-0399
LogicBio Therapeutics, Inc. (Filer) CIK: 0001664106 (see all company filings)

IRS No.: 471514975 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38707 | Film No.: 211018541
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences